Although BETi suppresses MYC expression by interrupting BRD4 binding at the BENC super enhancer in BETi-resistant leukemia cells47, newly formed enhancer at the PVT1 locus re-drives MYC expression during BETi treatment and mediate the BETi resistance. Here, BRD4 is linked to leukemia.